南昌哪个医院酒瘾-【南昌市第十二医院精神科】,南昌市第十二医院精神科,南昌那里看幻听好些,南昌市治疗双向情感障碍的费用,南昌焦虑症好的治疗办法,南昌市治躁狂的医院有哪些,南昌那里专治神经病,南昌治疗焦虑症抑郁医院

BEIJING, Sept. 26 (Xinhuanet) -- Young unmarried migrant women are facing a high risk of induced abortions in China and experts urged that they have better access to reproductive health education.Among the 8 to 10 million induced abortions performed on the mainland each year, nearly 47 percent involve unmarried women younger than 25, according to Cheng Linan, director of the center for clinical research and training of the Shanghai Institute of Planned Parenthood Research.The statistics are based on the results from a recent nationwide survey."The rising trend of induced abortions is even more evident among migrants who usually have poor awareness and access to reproductive health knowledge and services, particularly about contraception," she said on Saturday at an event to mark World Contraceptive Day, which falls on Sept 26.A 2008 survey involving more than 50,000 induced abortions in Beijing showed that roughly 70 percent of the women undergoing the procedure were migrants. For many, it was not their first abortion.According to a nationwide study by the Chinese Medical Association (CMA), of all women having received induced abortions, nearly 56 percent had two operations and 13.5 percent had three or more."That not only causes the women certain physical or mental problems, but it also gives the country a huge economic burden of more than 3 billion yuan" or about 0 million, she said.Among Chinese women who became infertile, more than 88 percent previously had an induced abortion, a study conducted in 2007 showed.Other potential health hazards include hemorrhage, uterine or pelvic infection, uterine perforation and cervical laceration.Apart from low awareness, poor access to professional consultations on contraception, particularly among single young women, is mainly the problem.A 2011 survey by the CMA found that about 44 percent of those polled said they had difficulty accessing scientifically correct contraceptive information, compared with a global average of 15.5 percent.
BEIJING, July 11 (Xinhuanet) -- U.S. federal government officially announced that it denied the medical use of marijuana."Department of Health and Human Services concluded that marijuana has a high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision," U.S. Department of Justice declared Friday.The announcement will keep marijuana in the classification of dangerous, addictive drug as heroin.The decision comes almost nine years after medical marijuana advocates asked the government to reclassify marijuana, as its therapeutic effectiveness in treating some diseases and relieving pain of patients.Joe Elford, the chief counsel for Americans for Safe Access (ASA), said he was not surprised by the government's disapproval."It is clearly motivated by a political decision that is anti-marijuana," He noted.This is the third petition to reclassify marijuana has failed to be approved. The former two were filed in 1972 and in 1995, respectively.

WASHINGTON, July 8 (Xinhua) -- U.S. space shuttle Atlantis lifted off on Friday morning from Kennedy Space Center in Florida, on the 135th and final flight in NASA's shuttle program.The shuttle blasted off at about 11:29 a.m. EDT (1529 GMT) on a tower of flame, NASA TV showed.Before taking flight, shuttle Commander Christopher Ferguson saluted all those who contributed over the years to the shuttle program."The shuttle is always going to be a reflection of what a great nation can do when it dares to be bold and commits to follow through,'' he said. "We're not ending the journey today ... we're completing a chapter of a journey that will never end.''In this photo released by NASA, space shuttle Atlantis lifts off from NASA's Kennedy Space Center in Florida, the United States, July 8, 2011. U.S. space shuttle Atlantis lifted off at about 11:29 a.m. EDT (1529 GMT) on Friday from Kennedy Space Center in Florida, on the 135th and final flight in NASA's shuttle program.Atlantis's primary payload is an Italian-built cargo hauler named Raffaello which is loaded with 8,640 pounds (3,919 kgs) of food, clothing, supplies and science equipment to sustain space station operations after the shuttles are retired.Only four astronauts take to the skies because there is no shuttle available for a rescue flight should anything go wrong. Normally NASA sends six or seven astronauts on space shuttle flights -- with the last four-person shuttle crew launched 28 years ago.But Atlantis' status as the final flight means there is no other space shuttle on standby and the U.S. would have to call on Russia for any rescue operation. The Russian Soyuz capsules hold just three astronauts and at least one must be Russian, so two crew members would have to fly up and bring home the Americans from the International Space Station one at a time.The crew will also return an ammonia pump that recently failed on the station. Engineers want to understand why the pump failed and improve designs for future spacecraft. One spacewalk is planned during Atlantis' mission, though it will be conducted by NASA's two resident space station astronauts, rather than the shuttle crew.It is the 33rd voyage for Atlantis. Its return to the earth later this month will mark the end of the 30-year shuttle program.Atlantis will be the last shuttle to be retired. Discovery was first in March, followed by Endeavour at the beginning of June. Each shuttle will head to a museum.When the U.S. space shuttle program officially ends later this year, the Russian space program's Soyuz capsule will be the only method for transporting astronauts to and from the station.Space shuttles have made great contributions to U.S. space exploration. They allowed astronauts to not only launch satellites, but to grab and repair them and put them back into service. Most remarkably, they allowed NASA to regularly rejuvenate the Hubble Space Telescope, which for 21 years has produced images that are transforming astronomers' understanding of the universe. With their enormous cargo bays, the shuttles also enabled the United States and its partners to build the International Space Station.However, high costs, risks, policy shift force the U.S. to quit the space shuttle program.NASA originally estimated the program would cost about 90 billion U.S. dollars. However, its actual cost stands at about 200 billion dollars, compared with the 151 billion dollars spent on Apollo which took Americans to the moon in 1969.Seven astronauts perished when Challenger exploded about a minute after launch in 1986. Nearly two decades after the Challenger explosion, a new catastrophe shocked NASA when the shuttle Columbia disintegrated moments before landing in 2003.One out of every 67 flights ended in death. Based on deaths per million miles traveled, the space shuttle is 138 times riskier than a passenger jet.The panel that investigated the 2003 Columbia accident concluded: "It is in the nation's interest to replace the Shuttle as soon as possible.''The Obama administration wants to spur private companies to get into the space taxi business, freeing NASA to focus on deep space exploration and new technology development.During his first-ever Twitter town hall meeting on Wednesday, Obama said NASA needs new technology breakthroughs to revitalize its mission to explore the universe."The shuttle did some extraordinary work in low-orbit experiments, the International Space Station, moving cargo. It was an extraordinary accomplishment. And we're very proud of the work that it did," Obama said. "But now what we need is that next technological breakthrough."
BEIJING, Sept. 27 (Xinhuanet) -- Scientists have been making great efforts to show how harmful coffee is to us, though no evidence yet. A latest study may be reassuring for coffee-lovers.Women who drink caffeinated coffee are less likely to be depressed than those don't. And the more they drink, the lower risk of developing depression, according to a study published Monday in the Archives of Internal Medicine. Researchers of the study tracked the health of over 50,000 women aged between 30 and 55 in 1996 for a decade and recorded their mental health and coffee intake periodically.They find that women who drank two or three cups of coffee per day were 15 percent less likely than those who drank little or decaffeinated coffee to be depressed.And for those who drank four or more cups, the risk of developing depression reduced by 20 percent.The reason why coffee could protect depression is not clear. But the scientists from the Harvard University speculated that caffeine was the key player. More research is needed to show whether caffeine can ward off depression.It might be that not-depressed people tended to be more activated and the habit of coffee drinking just fit in their lifestyle.However, the depressed ones, who might suffer from sleeplessness, chose not to drink coffee because the caffeine might exacerbate it."There's no need to start drinking coffee," said Dr. Alberto Ascherio, the senior author of the study, "The message is that coffee is safe to drink, with no adverse effects. That's really all that can be said."
BEIJING, August 4 (Xinhuanet) -- Medtronic Inc. is giving Yale University a 2.5 million U.S. dollar grant to review the safety and effectiveness of its controversial spine treatment called Infuse Bone Graft, according to The Wall Street Journals Thursday.Under terms of the pact, the company will release to Yale and eventually the public what participants described as an unprecedented amount of clinical trial and other data. The university will select two research teams from other organizations to perform separate analyses of the data.The announcement comes in the wake of a paper in June in the Spine Journal. The paper revealed that several clinical studies of Infuse, conducted by surgeons with strong economic ties to Medtronic, failed to report serious complications that arose in the trials. The critical paper also found that many of the studies were designed in ways in favor of Infuse over a treatment given to a control group.Medtronic disputes some of the findings and is conducting an internal investigation of the matter.Infuse accounts for about 700 million dollars in annual sales for Medtronic. The product is under investigation by the Senate Finance Committee over the role payments to physicians who may have played how studies were reported.
来源:资阳报